Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Update on Activities

21 Sep 2006 16:29

Quadrise Fuels International PLC21 September 2006 Quadrise Fuels International plc ("Quadrise" or "the Company") AIM : QFI Update on Activities Following the Company's admission to AIM in April 2006, Quadrise has undertakencomprehensive business development activities and is pleased to announce thefollowing update. The Company's business is to manufacture and market low cost superior qualityfuel oil emulsions (MSAR(R)) from the least desirable elements of the oil barrel- namely the heaviest and most viscous fractions, which can be purchased at lowcost. These fractions are available to Quadrise by a number of means including: •Splitting heavy fuel oil, or heavy crude in its own facilities •Sourcing ultra heavy crude/bitumen and manufacturing MSAR(R) at the point of production •Purchasing vacuum residues from existing oil refineries Following admission, a comprehensive strategy review has been undertaken tore-appraise the Company's focus and target markets, of which a key result hasbeen a shift into larger projects, using as feedstock oil residues availablewithin existing oil refineries. Quadrise has selected the following markets astargets arising from its initial analysis: •Far East/South East Asia (Korea, Japan, Taiwan, China, Singapore) •Southern Europe & Mediterranean, including Italy, Greece & Turkey •NW Europe, including the UK •USA •Central America and Caribbean •Specific countries in Africa A programme of refinery visits has been initiated consistent with the selectedgeographic strategy. Specifically, formal submissions have been made to two FarEast refiners and one refinery in NW Europe. Positioning MSAR(R) within theserefineries' processing configurations offers the respective oil companiessignificant benefits - both reducing capital expenditure to process heavyresidues, and increasing operating flexibility and profit margins. Significantbenefits have been demonstrated for certain options already studied, andQuadrise has further new processing concepts in the pipeline. The Company's strategy is to offer a sink to refiners for their residues inorder to permit them to take advantage of these benefits, whilst providingQuadrise its feedstock for MSAR(R) manufacture and subsequent sale to therespective regional power generating markets. The Company's initial analysis in this area is very positive and a technicalpaper on the concepts developed by Quadrise will be presented at a major globalrefining conference dealing with bottom of the barrel conversion technologyduring the course of October. Effective in October, the Quadrise management team will be joined by JasonMiles, as Business Development Manager. He has previously led a number ofsuccessful commercial efforts for the sale of Orimulsion, which is the Company'sonly commercial competitor. Commenting on the hire, Bill Howe, CEO, stated "Jason brings excellentexperience and is conversant with a number of potential MSAR(R) consumers and webelieve he will strengthen our capability to close the power plant sales side ofour business deals." In parallel with the focused regional marketing activities, preliminary marketstudies are underway or planned in the Middle East, Russia, India, and SouthEast Asia - through to the end of 2006. A major island based power plantrefuelling opportunity is being pursued in the United States through QuadriseFuels US LP. Quadrise Canada Fuel Systems Inc. ("QCFS") has now secured its first commercialcontract for the Surmont SAGD (Steam Assisted Gravity Drainage) project forParamount Resources in northern Alberta, Canada. It will initially involve thesale of 3,000 BPD of MSAR(R), rising to 13,000 BPD, with the planned start upfor late 2009. QCFS have a number of other interesting prospects in hand andexpectations are positive regarding their participation in the growing SAGDdevelopments in Canada. Quadrise recently increased its shareholding in QCFS by0.6%. Bill Howe stated, "Going forward the Quadrise management team is extremelypositive about its operations and the attention the business development effortsare receiving from the market after this initial five months of activity." A statement regarding the Company's activities, from which the information inthis announcement has been extracted, has been circulated to shareholders and isalso available on the Company's website at www.quadrisefuels.com/news. For further information, please contact: Quadrise Fuels International plcBill HoweCEOT: +44 (0)20 7550 4930 Smith & Williamson Corporate Finance LimitedAzhic Basirov+44 (0)20 7131 4000 Parkgreen CommunicationsSimon Robinson /Victoria Thomas+44 (0)20 7493 3713 21 September 2006 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
29th Nov 20197:00 amRNSAGM Update
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.